Bariatric Surgery Beats GLP-1 RAs for Sustained Weight Loss
METHODOLOGY:
The use of GLP-1 RAs has surged over the years, but semaglutide and tirzepatide have rarely been directly compared with bariatric surgery, the gold standard for obesity and diabetes treatment.
Researchers conducted a retrospective study using electronic health records to compare the weight-loss effects of injectable GLP-1 RAs (semaglutide or tirzepatide) with those of bariatric surgery on adults with BMI ≥ 35.
They analyzed data of 38,545 patients who received GLP-1 RAs and 12,540 patients who underwent bariatric surgery via minimally invasive sleeve gastrectomy or Roux en-Y gastric bypass between 2018 and 2024.
Percent total weight loss was compared over a 3-year follow-up period.
TAKEAWAY:
Patients who received GLP-1 RAs had significantly higher rates of diabetes, hyperlipemia, and chronic obstructive pulmonary disease than those who underwent surgery.
After 3 years, patients who underwent bariatric surgery experienced a 23.3% total weight loss (95% CI, -23.5 to -23.1), whereas those who used GLP-1 RAs had a 4% total weight loss (95% CI, -4.1 to -3.8).
Patients who used GLP-1 RAs continuously for 1 year lost 5.9% of their total weight, but weight loss was still significantly greater in those who underwent bariatric surgery (22.2%).
IN PRACTICE:
'Clinical trials show weight loss between 15% to 21% for GLP-1s, but this study suggests that weight loss in the real world is considerably lower even for patients who have active prescriptions for an entire year. We know as many as 70% of patients may discontinue treatment within 1 year. GLP-1 patients may need to adjust their expectations, adhere more closely to treatment, or opt for metabolic and bariatric surgery to achieve desired results,' said the lead author in a news release.
SOURCE:
This study was led by Avery Brown, MD, a surgical resident at NYU Langone Health in New York City. It was presented on June 17, 2025, at the American Society for Metabolic and Bariatric Surgery 2025 Annual Scientific Meeting at the Gaylord National Resort & Convention Center in National Harbor, Maryland.
LIMITATIONS:
The authors did not report any specific limitations.
DISCLOSURES:
This study received support from a NYU Clinical and Translational Science Awards grant from the National Center for Advancing Translational Sciences and another grant from the National Institute of Allergy and Infectious Diseases.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
U.S. Alcohol Consumption Hits 90-Year Low - Zero-Proof Spirits Like Arkay and Beyond Spirits Are Filling the Gap
Health-conscious Americans are swapping liquor for plant-based, alcohol-free alternatives Miami, Florida--(Newsfile Corp. - August 15, 2025) - For the first time in nearly a century, alcohol consumption in the United States has fallen to historic lows. A surprising driver behind this shift? Younger, health-conscious consumers who are drinking less - or not at all - in favor of mindful, wellness-oriented lifestyles. This decline in traditional liquor sales is not a sign of the end for social drinking. Instead, it marks the beginning of a new era - one led by zero-proof spirits like Arkay Beverages and Beyond Spirits, the world's first plant-based, alcohol-free whisky. "We are witnessing the biggest drinking culture transformation in 90 years," said Reynald Vito Grattagliano, founder of Arkay Beverages and Beyond Spirits. "Consumers still want the taste, ritual, and social connection of spirits - but without the downsides of alcohol. Our zero-proof innovations deliver exactly that." According to industry analysts, several factors are fueling this trend: Gen Z & Millennials are choosing moderation and alcohol-free lifestyles at unprecedented rates. Health and wellness priorities are shifting spending toward low- and no-alcohol options. Innovation in taste and quality has made zero-proof spirits a viable alternative to traditional liquor. Arkay and Beyond Spirits stand at the forefront of this shift. Arkay offers a wide range of zero-proof alternatives to popular spirits - from whisky and rum to tequila and gin - all made without sugar, artificial sweeteners, or calories. Beyond Spirits takes plant-based innovation to the next level with its alcohol-free whisky crafted from 100% natural, sustainable ingredients. Why Zero-Proof Spirits Are the Future: Social without the hangover: Enjoy the experience of a night out without next-day regrets. Inclusive drinking culture: Alcohol-free options allow everyone to participate - from sober-curious to designated drivers. Better for body and mind: Supports mental clarity, fitness goals, and overall wellness. "This isn't a fad - it's a global movement," added Grattagliano. "Alcohol consumption may be at a 90-year low, but social connection and celebration are stronger than ever. Zero-proof spirits are the bridge between tradition and tomorrow." As Americans turn away from liquor, brands like Arkay and Beyond Spirits are proving that the future of drinking is not about alcohol - it's about choice, health, and innovation. About Arkay Beverages Founded in 2011, Arkay Beverages pioneered the zero-proof spirits category, offering alcohol-free alternatives to classic liquors. Each product is crafted to deliver the authentic taste of spirits without alcohol, sugar, or calories. About Beyond Spirits Beyond Spirits is the creator of the world's first plant-based, alcohol-free whisky. Combining innovation, sustainability, and craftsmanship, the brand delivers a premium drinking experience for health-conscious consumers worldwide. Press Contact: Person Name:Reynald Vito Grattagliano Media RelationsArkay Beverages & Beyond SpiritsEmail: press@ | To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Gizmodo
14 minutes ago
- Gizmodo
DARPA Is Taking Its AI Fighter Jet Program to the Next Level
Imagine Top Gun without pilots. Not exactly summer blockbuster material. But that is what the Defense Advanced Research Projects Agency (DARPA) has in mind for the future of the military. According to an announcement spotted by The Register, the agency recently handed out a multi-million dollar contract that will push forward its autonomous pilot program that will eventually deploy planes into warfare without a human being behind the control stick. The contract, announced earlier this week, was awarded to Systems and Technology Research, a real company and not a front with the most vague name imaginable, and will provide the company with $11.3 million to work on DARPA's Artificial Intelligence Reinforcements (AIR) program. The contract is for phase two of the project, which DARPA describes as 'Developing AI-driven algorithmic approaches which enable real-time distributed autonomous tactical execution within uncertain, dynamic, and complex operational environments.' Which seems like it's probably a very technical way of saying 'operating in the air.' The expectation of the agency is that Systems and Technology Research and any other contractor participating in the program develop these systems using existing sensor and weapons technologies. They will be required, through a series of tests and simulations, to eventually meet some currently undefined benchmarks that show the capability of producing 'an uncrewed combat aerial vehicle.' According to DARPA, the AIR program aims to develop 'AI-driven tactical autonomy' that can eventually deploy unmanned combat aerial vehicles (UCAV) as part of air combat missions. The program is something of a stage two to the agency's Air Combat Evolution initiative, which previously managed to allow AI to take control of an F-16 mid-flight and engage in dogfights against human pilots. An AI system developed as part of ACE previously beat human pilots in virtual dogfights, as well. Systems and Technology Research appears to be the first company to receive an invitation into phase two of DARPA's program, suggesting it has already completed the first stated goal of 'Creating fast and accurate models that capture uncertainty and automatically improve with more data.' According to The Register, defense contracting giants Lockheed Martin and BAE Systems have also been involved in the first stages of the program, but have not been confirmed to be a part of phase two, which will see DARPA shrink its group of prospective contractors from six to four. DARPA has its eyes on the skies with this program, but it is also going autonomous in the seas. Earlier this week, it announced the christening of the USX-1 Defiant, a first-of-its-kind autonomous, unmanned surface vessel, and announced that it was preparing it for the launch of its first at-sea demonstration.
UPI
15 minutes ago
- UPI
PFAS chemicals tied to weight loss difficulties in teens
"Forever" PFAS chemicals might hamper a teenager's ability to drop excess weight, even if they've undergone weight-loss surgery, University of Southern California researchers said in a new study. File Photo by Diego Azubel/EPA "Forever" PFAS chemicals might hamper a teenager's ability to drop excess weight, even if they've undergone weight-loss surgery, a new study says. Teens with high blood levels of per- and polyfluoroalkyl substances were more likely to regain weight lost after bariatric surgery, researchers reported Aug. 14 in the journal Obesity. "Our study shows a clear association between PFAS exposure and weight-related outcomes in bariatric surgery for adolescents," lead researcher Brittney Baumert said in a news release. She's a postdoctoral research fellow in population and public health sciences at the Keck School of Medicine of USC. PFAS are called "forever chemicals" because they combine carbon and fluorine molecules, one of the strongest chemical bonds possible. This makes PFAS removal and breakdown very difficult. PFAS compounds have been used in consumer products since the 1940s, including fire extinguishing foam, nonstick cookware, stain-resistant furniture, waterproof clothing and food wrappers, researchers said. Previous studies have shown that PFAS chemicals disrupt hormones in the human body, potentially affecting metabolism and weight gain, researchers said in background notes. "With the growing use of weight loss interventions around the world, it's critical for us to understand the association between PFAS and successful weight loss management, including what this means for long-term outcomes," Baumert said. For the study, researchers tracked 186 teenagers who underwent bariatric surgery between 2007 and 2012. Blood samples were taken before surgery and tested for seven types of PFAS, and the participants were tracked for up to five years after surgery for weight, body mass index and waist size. (BMI is an estimate of body fat based on height and weight.) Results showed that teens with higher PFAS blood levels before surgery regained more weight and had greater increases in waist circumference than those with lower levels. The strongest links between the chemicals and excess weight were observed in a class of PFAS known as sulfonic acids, which includes perfluoroctaansulfonaten, or PFOS, and perfluoroheptanesulfonic acid, or PFHpS, researchers said. For example, teenagers with the highest levels of PFOS regained about 47 pounds on average within five years of their surgery, compared with about 36 pounds for those with the lowest exposure levels, results showed. And teens with highest PFHpS exposure regained an average 4.3% of their body weight per year following surgery, compared with 2.7% per year in the lowest exposure group. These results add to mounting evidence that PFAS need stronger regulation, researchers said. This particularly applies to public water supplies, which are the greatest source of PFAS exposure in the U.S. "PFAS are a modifiable risk, which is why protective policies are so important to reduce exposure and safeguard public health -- especially for vulnerable populations," Baumert said. Researchers next plan to explore whether PFAS exposure might affect the impact of other weight-loss methods, such as GLP-1 drugs like Ozempic and Zepbound. They also want to investigate whether PFAS chemicals increase risk of metabolic conditions like type 2 diabetes or fatty liver disease. However, they noted the current study is observational and cannot draw a direct cause-and-effect link between PFAS and weight gain. More information The Environmental Working Group has more on PFAS chemicals. Copyright © 2025 HealthDay. All rights reserved.
